Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 204 participants.
Also called NCT01555658
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 204 participants
- Registry
-
NCT01555658
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01555658. Randomized; no masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2012-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
- Acronym
- BILLION
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Bivalirudin
- Intervention (Drug)
- Unfractioned Heparin
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01555658- Content hash
85cc818c7297c962079a02f067fb590886a090988f3f48d90e8ac8d266d37e05